Aurobindo Pharma USA, Inc.

Cases where party is a Patent Asserter

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 1 - 34 of 34
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al 1:24-cv-00698 D.Del.
Amicus Therapeutics, Inc.
2 Amicus Therapeutics US, LLC et al v. Aurobindo Pharma Ltd. et al 1:24-cv-00698 D.Del.
Amicus Therapeutics US, LLC
3 ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al 3:24-cv-04403 D.N.J.
Merck Sharp & Dohme LLC
4 ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al 3:24-cv-04403 D.N.J.
Allergan Pharmaceuticals International Limited
5 ABBVIE INC. et al v. AUROBINDO PHARMA U.S.A., INC. et al 3:24-cv-04403 D.N.J.
AbbVie Inc.
6 Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al 1:23-cv-00582 D.Del.
  • 8 Product company
Vertex Pharmaceuticals Incorporated
7 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
  • 8 Product company
  • 12 IP subsidiary of product company
Theravance Biopharma R&D IP, LLC
8 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
  • 8 Product company
  • 12 IP subsidiary of product company
Mylan Ireland LTD.
9 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
  • 8 Product company
  • 12 IP subsidiary of product company
Mylan Specialty, L.P.
10 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
  • 8 Product company
  • 12 IP subsidiary of product company
Theravance Biopharma Ireland Limited
11 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
  • 8 Product company
  • 12 IP subsidiary of product company
Theravance Biopharma US, Inc.
12 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
  • 8 Product company
Merck Serono SA
13 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
  • 8 Product company
Merck KGaA
14 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
  • 8 Product company
Ares Trading SA
15 Alcon Inc. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01391 D.Del.
  • 8 Product company
Alcon Laboratories, Inc.
16 Alcon Inc. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01391 D.Del.
  • 8 Product company
Alcon Inc.
17 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
  • 8 Product company
Merck Serono SA
18 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
  • 8 Product company
Merck KGaA
19 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
  • 8 Product company
Ares Trading SA
20 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Sunovion Pharmaceuticals Inc.
21 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Bial - Portela & CA S.A.
22 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Bial - Holding, S.A.
23 Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al 1:22-cv-00971 D.Del.
  • 8 Product company
Covis Pharma GmbH
24 Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al 1:22-cv-00971 D.Del.
  • 8 Product company
AMAG Pharmaceuticals, Inc.
25 BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al 3:22-cv-02345 D.N.J.
  • 8 Product company
Merck & Cie
26 BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al 3:22-cv-02345 D.N.J.
  • 8 Product company
BioMarin Pharmaceutical Inc.
27 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Teva Pharmaceuticals International GmbH
28 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Eagle Pharmaceuticals, Inc.
29 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Cephalon, Inc.
30 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Cilag GMBH (International)
31 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Mitsubishi Tanabe Pharma Corp.
32 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Research & Development LLC
33 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Pharmaceuticals Inc.
34 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Pharmaceutica